Biomodulatory role of ceramide in basic fibroblast growth factor-induced proliferation of cerebellar astrocytes in primary culture

Laura Riboni, Paola Viani, Rosaria Bassi, Angela Stabilini, Guido Tettamanti

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

To evaluate the role of ceramide in glial growth, primary cultures of quiescent astrocytes from rat cerebellum were stimulated to proliferate by mitogenic doses of basic fibroblast growth factor (bFGF). Parallel to the bFGF mitogenic effect was a marked, and persistent, decrease in cellular ceramide levels. Both in vitro and in culture metabolic studies have led us to exclude both sphingomyelinase and ceramidase involvement in ceramide level variation. Instead, we found evidence of a functional connection between the decrease in ceramide levels and astrocyte proliferation. In fact, cell growth in bFGF-stimulated astrocytes was inhibited by exogenous ceramide and C2-ceramide, maximal inhibition being obtained at a ceramide concentration of 5-10 μM. Under the same conditions, the dihydroderivatives of ceramides were without effect. Following ceramide treatment, the phosphorylation of the MAP kinase isoforms ERK1/2, key components in bFGF-induced cell proliferation, was examined. The administration of antiproliferative doses of ceramide or C2-ceramide, but not of their dihydroderivatives, resulted in a significant inhibition of ERK1/2 activation. In conclusion, our data indicate that the prompt modulation of ceramide levels by bFGF is an early step associated with the signaling pathways responsible for the mitogenic activity of bFGF in astrocytes. (C) 2000 Wiley-Liss, Inc.

Original languageEnglish
Pages (from-to)137-145
Number of pages9
JournalGLIA
Volume32
Issue number2
DOIs
Publication statusPublished - 2000

Fingerprint

Ceramides
Fibroblast Growth Factor 2
Astrocytes
Ceramidases
Sphingomyelin Phosphodiesterase
Mitogen-Activated Protein Kinase 3
Growth
Neuroglia
Cerebellum
Protein Isoforms
Phosphorylation
Cell Proliferation

Keywords

  • Cell growth
  • Extracellular signal-regulated kinase
  • Glial cells
  • Sphingolipids

ASJC Scopus subject areas

  • Immunology

Cite this

Biomodulatory role of ceramide in basic fibroblast growth factor-induced proliferation of cerebellar astrocytes in primary culture. / Riboni, Laura; Viani, Paola; Bassi, Rosaria; Stabilini, Angela; Tettamanti, Guido.

In: GLIA, Vol. 32, No. 2, 2000, p. 137-145.

Research output: Contribution to journalArticle

Riboni, Laura ; Viani, Paola ; Bassi, Rosaria ; Stabilini, Angela ; Tettamanti, Guido. / Biomodulatory role of ceramide in basic fibroblast growth factor-induced proliferation of cerebellar astrocytes in primary culture. In: GLIA. 2000 ; Vol. 32, No. 2. pp. 137-145.
@article{623a9aef2afa4ac88bc1f9fee96f6a0a,
title = "Biomodulatory role of ceramide in basic fibroblast growth factor-induced proliferation of cerebellar astrocytes in primary culture",
abstract = "To evaluate the role of ceramide in glial growth, primary cultures of quiescent astrocytes from rat cerebellum were stimulated to proliferate by mitogenic doses of basic fibroblast growth factor (bFGF). Parallel to the bFGF mitogenic effect was a marked, and persistent, decrease in cellular ceramide levels. Both in vitro and in culture metabolic studies have led us to exclude both sphingomyelinase and ceramidase involvement in ceramide level variation. Instead, we found evidence of a functional connection between the decrease in ceramide levels and astrocyte proliferation. In fact, cell growth in bFGF-stimulated astrocytes was inhibited by exogenous ceramide and C2-ceramide, maximal inhibition being obtained at a ceramide concentration of 5-10 μM. Under the same conditions, the dihydroderivatives of ceramides were without effect. Following ceramide treatment, the phosphorylation of the MAP kinase isoforms ERK1/2, key components in bFGF-induced cell proliferation, was examined. The administration of antiproliferative doses of ceramide or C2-ceramide, but not of their dihydroderivatives, resulted in a significant inhibition of ERK1/2 activation. In conclusion, our data indicate that the prompt modulation of ceramide levels by bFGF is an early step associated with the signaling pathways responsible for the mitogenic activity of bFGF in astrocytes. (C) 2000 Wiley-Liss, Inc.",
keywords = "Cell growth, Extracellular signal-regulated kinase, Glial cells, Sphingolipids",
author = "Laura Riboni and Paola Viani and Rosaria Bassi and Angela Stabilini and Guido Tettamanti",
year = "2000",
doi = "10.1002/1098-1136(200011)32:2<137::AID-GLIA30>3.0.CO;2-2",
language = "English",
volume = "32",
pages = "137--145",
journal = "GLIA",
issn = "0894-1491",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - Biomodulatory role of ceramide in basic fibroblast growth factor-induced proliferation of cerebellar astrocytes in primary culture

AU - Riboni, Laura

AU - Viani, Paola

AU - Bassi, Rosaria

AU - Stabilini, Angela

AU - Tettamanti, Guido

PY - 2000

Y1 - 2000

N2 - To evaluate the role of ceramide in glial growth, primary cultures of quiescent astrocytes from rat cerebellum were stimulated to proliferate by mitogenic doses of basic fibroblast growth factor (bFGF). Parallel to the bFGF mitogenic effect was a marked, and persistent, decrease in cellular ceramide levels. Both in vitro and in culture metabolic studies have led us to exclude both sphingomyelinase and ceramidase involvement in ceramide level variation. Instead, we found evidence of a functional connection between the decrease in ceramide levels and astrocyte proliferation. In fact, cell growth in bFGF-stimulated astrocytes was inhibited by exogenous ceramide and C2-ceramide, maximal inhibition being obtained at a ceramide concentration of 5-10 μM. Under the same conditions, the dihydroderivatives of ceramides were without effect. Following ceramide treatment, the phosphorylation of the MAP kinase isoforms ERK1/2, key components in bFGF-induced cell proliferation, was examined. The administration of antiproliferative doses of ceramide or C2-ceramide, but not of their dihydroderivatives, resulted in a significant inhibition of ERK1/2 activation. In conclusion, our data indicate that the prompt modulation of ceramide levels by bFGF is an early step associated with the signaling pathways responsible for the mitogenic activity of bFGF in astrocytes. (C) 2000 Wiley-Liss, Inc.

AB - To evaluate the role of ceramide in glial growth, primary cultures of quiescent astrocytes from rat cerebellum were stimulated to proliferate by mitogenic doses of basic fibroblast growth factor (bFGF). Parallel to the bFGF mitogenic effect was a marked, and persistent, decrease in cellular ceramide levels. Both in vitro and in culture metabolic studies have led us to exclude both sphingomyelinase and ceramidase involvement in ceramide level variation. Instead, we found evidence of a functional connection between the decrease in ceramide levels and astrocyte proliferation. In fact, cell growth in bFGF-stimulated astrocytes was inhibited by exogenous ceramide and C2-ceramide, maximal inhibition being obtained at a ceramide concentration of 5-10 μM. Under the same conditions, the dihydroderivatives of ceramides were without effect. Following ceramide treatment, the phosphorylation of the MAP kinase isoforms ERK1/2, key components in bFGF-induced cell proliferation, was examined. The administration of antiproliferative doses of ceramide or C2-ceramide, but not of their dihydroderivatives, resulted in a significant inhibition of ERK1/2 activation. In conclusion, our data indicate that the prompt modulation of ceramide levels by bFGF is an early step associated with the signaling pathways responsible for the mitogenic activity of bFGF in astrocytes. (C) 2000 Wiley-Liss, Inc.

KW - Cell growth

KW - Extracellular signal-regulated kinase

KW - Glial cells

KW - Sphingolipids

UR - http://www.scopus.com/inward/record.url?scp=0033787676&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033787676&partnerID=8YFLogxK

U2 - 10.1002/1098-1136(200011)32:2<137::AID-GLIA30>3.0.CO;2-2

DO - 10.1002/1098-1136(200011)32:2<137::AID-GLIA30>3.0.CO;2-2

M3 - Article

C2 - 11008213

AN - SCOPUS:0033787676

VL - 32

SP - 137

EP - 145

JO - GLIA

JF - GLIA

SN - 0894-1491

IS - 2

ER -